PZZA vs DMII
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PZZA · Papa John's$19.73 ▼ 0.80%
DMII · DRUGS MADE IN AMERICA ACQ II CORP$10.21 ▼ 0.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PZZA -52.7%
- DMII +3.3%
Head to head
| Metric | PZZA | DMII |
|---|---|---|
| Price | $19.73 | $10.21 |
| Change today | ▼ 0.80% | ▼ 0.10% |
| Market cap | $649.97M | $650.38M |
| Return, 3 months | -17.3% | +0.9% |
| Return, year to date | -47.4% | +3.1% |
| Return, 1 year | -50.1% | – |
| P/E (TTM) | 26.0 | 35.0 |
| P/B | -1.5 | 1.3 |
| P/E percentile vs own 5y | 37th | 63rd |
| Dividend yield | 6.99% | – |
| Revenue growth (YoY, latest qtr) | -8.8% | – |
| Net profit growth (YoY) | -10.0% | +11,647.4% |
| Gross margin | 20.2% | – |
| Operating margin | 4.1% | – |
| Net margin | 1.4% | – |
| Return on equity | – | 5.3% |
| Analyst target vs. price | +31.8% | – |
| Analyst buy share | 20% | – |
| RSI (14) | 53 | 62 |
| 30-day volatility | 34.6% | 0.9% |
| Max drawdown, 1 year | -64.2% | -0.7% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Hold | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DMII is the largest of the group by market value.
- PZZA carries the lowest trailing P/E.
- DMII has been the calmest stock over the last 30 days.